The Global Mucopolysaccharidosis (MPS) Treatment Industry is on the brink of a transformative journey, set to make significant strides and reach an anticipated valuation of approximately US$2.38 billion in 2022. These promising prospects come to light through an exhaustive market study conducted by Forecasted Market Insights (FMI), forecasting an impressive Compound Annual Growth Rate (CAGR) …